Cleared Traditional

ROCHE ABUSCREEN ONTRAK FOR METHADONE

K930845 · Roche Diagnostic Systems, Inc. · Toxicology
Apr 1993
Decision
61d
Days
Class 2
Risk

About This 510(k) Submission

K930845 is an FDA 510(k) clearance for the ROCHE ABUSCREEN ONTRAK FOR METHADONE, a Hemagglutination Inhibition, Methadone (Class II — Special Controls, product code DIW), submitted by Roche Diagnostic Systems, Inc. (Branchburg, US). The FDA issued a Cleared decision on April 20, 1993, 61 days after receiving the submission on February 18, 1993. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3620.

Submission Details

510(k) Number K930845 FDA.gov
FDA Decision Cleared SESE
Date Received February 18, 1993
Decision Date April 20, 1993
Days to Decision 61 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code DIW — Hemagglutination Inhibition, Methadone
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3620